• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Colorectal Cancer Endpoints Meeting Anouncement

The Food and Drug Administration (FDA) is holding a public workshop on endpoints for colorectal cancer. Issues identified in the workshop will be further discussed before the Oncologic Drugs Advisory Committee (ODAC) and thereafter will be detailed in FDA Guidance Documents.

DATE: November 12, 2003, from 8:00 a.m. to 5:00 p.m.

ADDRESS: Marriott Wardman Park Hotel, 2660 Woodley Road, NW, Washington, DC 20008.  Marriott Ballroom Salon 1 .  (Phone: 202/328-2000; Metro: Woodley Park – Zoo station on the red line).

REGISTRATION: No registration is required to attend the meeting. Seating will be available for 150 people on a first-come, first-served basis.

Dianne Spillman, Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857.  Phone: 301-594-5746.  Email: spillmand@cder.fda.gov